Monte Rosa Therapeutics Inc (GLUE)
8.48
-0.15
(-1.74%)
USD |
NASDAQ |
Nov 14, 16:00
8.48
0.00 (0.00%)
After-Hours: 05:12
Monte Rosa Therapeutics Shareholders Equity (Quarterly): 224.67M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 224.67M |
| March 31, 2024 | 152.52M |
| December 31, 2023 | 179.25M |
| September 30, 2023 | 184.52M |
| June 30, 2023 | 213.65M |
| March 31, 2023 | 243.73M |
| December 31, 2022 | 271.41M |
| September 30, 2022 | 291.09M |
| Date | Value |
|---|---|
| June 30, 2022 | 302.05M |
| March 31, 2022 | 325.88M |
| December 31, 2021 | 347.52M |
| September 30, 2021 | 369.30M |
| June 30, 2021 | 356.68M |
| March 31, 2021 | -60.62M |
| December 31, 2020 | -48.73M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-60.62M
Minimum
Mar 2021
369.30M
Maximum
Sep 2021
223.53M
Average
243.73M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
| Novartis AG | 43.32B |
| MEI Pharma Inc | 33.02M |
| Evoke Pharma Inc | 4.387M |
| Revance Therapeutics Inc | -163.03M |
| Vera Therapeutics Inc | 289.06M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 344.11M |
| Total Liabilities (Quarterly) | 119.44M |
| Current Ratio | 6.562 |